Title |
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib
|
---|---|
Published in |
Breast cancer targets and therapy, May 2021
|
DOI | 10.2147/bctt.s268451 |
Pubmed ID | |
Authors |
Lara Ulrich, Alicia F C Okines |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 45 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 13% |
Student > Bachelor | 5 | 11% |
Student > Ph. D. Student | 4 | 9% |
Other | 3 | 7% |
Unspecified | 2 | 4% |
Other | 6 | 13% |
Unknown | 19 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 11% |
Biochemistry, Genetics and Molecular Biology | 4 | 9% |
Medicine and Dentistry | 4 | 9% |
Chemistry | 3 | 7% |
Immunology and Microbiology | 2 | 4% |
Other | 7 | 16% |
Unknown | 20 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2022.
All research outputs
#17,438,425
of 25,584,565 outputs
Outputs from Breast cancer targets and therapy
#180
of 322 outputs
Outputs of similar age
#282,924
of 455,285 outputs
Outputs of similar age from Breast cancer targets and therapy
#10
of 13 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 322 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,285 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.